
MarketsMOJO Downgrades TCM Ltd to Strong Sell Amid Technical and Fundamental Weakness
2026-03-24 08:11:55TCM Ltd, a micro-cap player in the commodity chemicals sector, has been downgraded from a Sell to a Strong Sell rating following a comprehensive reassessment of its quality, valuation, financial trend, and technical indicators. The downgrade reflects deteriorating fundamentals, subdued financial performance, and a shift in technical momentum, signalling heightened risks for investors.
Read full news article
MarketsMOJO Upgrades TCM Ltd Rating to Sell Amid Mixed Technical and Financial Signals
2026-03-17 08:12:16TCM Ltd, a micro-cap player in the commodity chemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 16 March 2026. This change reflects a nuanced shift primarily driven by technical indicators, even as the company continues to grapple with weak financial fundamentals and challenging valuation metrics.
Read full news article
MarketsMOJO Downgrades TCM Ltd to Strong Sell Amid Technical and Financial Weakness
2026-03-10 08:09:27TCM Ltd, a player in the commodity chemicals sector, has seen its investment rating downgraded from Sell to Strong Sell as of 9 March 2026. This shift reflects deteriorating fundamentals, challenging valuation metrics, and a complex technical outlook, signalling heightened risk for investors amid a volatile market environment.
Read full news article
TCM Ltd is Rated Sell by MarketsMOJO
2026-03-06 10:11:01TCM Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 March 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.
Read full news article
TCM Ltd is Rated Sell by MarketsMOJO
2026-02-22 10:10:41TCM Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 February 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
TCM Ltd Reports Stabilised Quarterly Performance Amid Revenue Decline
2026-02-16 08:00:32TCM Ltd, a player in the commodity chemicals sector, has reported a flat financial performance for the quarter ended December 2025, signalling a stabilisation after a period of decline. Despite a modest improvement in its financial trend score, the company continues to face challenges with net sales contracting and a cautious market outlook reflected in its current Mojo Grade of Sell.
Read full news articleAre TCM Ltd latest results good or bad?
2026-02-14 19:39:51TCM Ltd's latest financial results for Q3 FY26 highlight ongoing operational challenges as the company continues its transition from traditional chemical manufacturing to solar panel trading and cattle feed production. The reported net loss for the quarter was ₹1.14 crores, which reflects a sequential narrowing of losses by 46.15% from the previous quarter. However, this represents a year-on-year increase in losses of 32.56%, indicating that the company is struggling to achieve sustainable operational improvements despite management's restructuring efforts. Revenue for Q3 FY26 was ₹5.69 crores, marking a decline of 7.93% compared to the same quarter last year and a decrease of 3.89% from the previous quarter. This ongoing revenue decline suggests weak demand conditions and challenges in market penetration within the company's new operational segments. The operating margin for the quarter stood at -9.67%, ...
Read full news article
TCM Ltd Q3 FY26: Losses Persist as Turnaround Remains Elusive
2026-02-13 14:53:56TCM Limited, the micro-cap commodity chemicals firm formerly known as Travancore Chemical & Manufacturing Company Limited, reported a consolidated net loss of ₹1.14 crores for Q3 FY26, marking the company's ninth consecutive quarterly loss. Despite a marginal improvement in losses compared to the previous quarter, the company's operational struggles continue to weigh heavily on investor sentiment, with the stock trading at ₹53.00 and commanding a market capitalisation of just ₹39.63 crores.
Read full news article
TCM Ltd is Rated Strong Sell
2026-02-10 10:11:11TCM Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 05 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 February 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.
Read full news articleBoard Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday 17Th February 2026
17-Feb-2026 | Source : BSEThe Board of Directors of the Company in its meeting held on Tuesday 17th February 2026 at 02:00 PM at the registered office of the Company on a shorter notice with the consent of all the directors has considered and approved the following business:- 1. Authorized Mr. Joseph Varghese Managing Director to accept a Term Loan of Rs. 1.37 Crore (Rupees One Crore Thirty Seven Lakh Only) at a Rate of Interest of 9.60% (Variable) floating from Indian Bank Vytilla Branch Ernakulam to be repaid in residual 174 EMIs commencing after 6 months holiday period with interest to be serviced as and when debited and holiday period to commence immediately after disbursement on mortgaging Door nos. 8/96-2 & 3 of our Hi-Lite property Maradu Ernakulam for our working capital needs. The meeting commenced at 02:00 PM and concluded at 02:45 PM. Kindly take the same on records.
Announcement under Regulation 30 (LODR)-Newspaper Publication
16-Feb-2026 | Source : BSEPursuant to Regulations 30 and 47 of SEBI(LODR) Regulations 2015 we are forwarding herewith copies of Newspaper clippings regarding Unaudited Consolidated & Standalone Financial Results for the Quarter ended 31st December 2025 published on Saturday 14th February 2026 in Financial Express in English language and Deepika in vernacular daily. Kindly take the same on records. Thank you
Board Meeting Outcome for Outcome Of The Board Meeting Held On 13Th February 2026 And The Consolidated And Standalone Unaudited Financial Results Along With The Consolidated And Standalone Limited Review Reports For The Quarter Ended 31St December 2025
13-Feb-2026 | Source : BSEThe Board of Directors of the Company in its meeting held on Friday 13th February 2026 has considered and approved the following business:- 1. The Consolidated and Standalone Unaudited Financial Results of the Company along with the Consolidated and Standalone Limited Review Reports for the Quarter ended 31st December 2025. The meeting commenced at 10.30 A.M. and concluded at 12:00 P.M. Pursuant to Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 we are enclosing herewith the Unaudited Standalone and Consolidated Financial Results for the first quarter ended 31st December 2025 along with a copy of Limited Review Reports issued by the Auditors of the Company. Kindly take the same on records. Thank you
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
TCM Ltd has announced 6:5 rights issue, ex-date: 26 Apr 22






